Infinity Pharmaceuticals, Inc.
INFIQ · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,956 | -$11,045 | -$9,230 | -$10,717 |
| Dep. & Amort. | $106 | $105 | $106 | $111 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $856 | $1,774 | $1,022 | $0 |
| Change in WC | $1,250 | -$2,848 | -$555 | $595 |
| Other Non-Cash | -$263 | -$562 | -$243 | $865 |
| Operating Cash Flow | -$8,007 | -$12,576 | -$8,900 | -$9,401 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$19 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $10,750 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $10,731 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $16 | $0 | $31 | $14 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $16 | $0 | $0 | $0 |
| Financing Cash Flow | $16 | $0 | $31 | $14 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,991 | -$12,576 | -$8,869 | $1,344 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $25,895 | $38,471 | $47,340 | $45,838 |
| End Cash | $17,904 | $25,895 | $38,471 | $47,182 |
| Free Cash Flow | -$8,007 | -$12,576 | -$8,900 | -$9,401 |